Skip to content
Screener

AngioDynamics ANGO Total Liabilities & Equity

Total Liabilities & Equity at other companies

Abbott logo
AbbottABT
$109.22B+30.0%
Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$50.73B-7.6%
TFX
TeleflexTFX
$6.79B-8.0%
Stryker logo
StrykerSYK
$47.93B+3.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$2.72B+10.2%
ICU Medical logo
ICU MedicalICUI
$3.97B-3.3%

Other financials

Income statement

See full
Revenue$86.6M+8.0%
Gross profit$46.8M+10.8%
Operating income-$10.2M-76.1%
Net income-$11.4M-88.5%
EPS (diluted)-$0.27-80.0%

Balance sheet

See full
Cash & equivalents$53.9M-3.6%
Total debt$11.0M+8.0%
Total equity$170.8M-6.6%
Total assets$267.2M-4.6%

Cash flow

See full
Operating cash flow$17.5M
CapEx$413.0K-46.8%
Free cash flow$17.0M

Valuation

See full
Market cap$648.51M+88.9%
Enterprise value$605.6M+103%
P/S+0.9×

Profitability

See full
Gross margin54.6%+0.7pp
Operating margin-12.5%-1.0pp
Net margin-11.5%-0.1pp
FCF margin0.2%

Returns & leverage

See full
Return on equity-20.8%+4.8pp
Debt / equity0.1×0.0×
Current ratio2.2×0.0×

Where this comes from

Reported directly by AngioDynamics in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesAndStockholdersEquity.

The source filing: AngioDynamics’s 10-K, filed July 14, 2026.

Filed
Jul 14, 2026, 3:42 PM EDT
Fiscal year
FY2026
Accession
0001628280-26-048138
Line itemMay 31, 2026May 31, 2025
Preferred stock, par value $0.01 per share, 5,000,000 shares authorized; no shares issued and outstanding
Common stock, par value $0.01 per share, 75,000,000 shares authorized; 42,314,266 and 41,607,877 shares issued and 41,700,419 and 40,994,030 shares outstanding at May 31, 2026 and 2025, respectively387385
Additional paid-in capital636,083621,186
Accumulated deficit(465,939)(429,197)
Treasury stock, 613,847 shares, at cost at May 31, 2026 and 2025, respectively(7,381)(7,381)
Accumulated other comprehensive loss7,675(2,023)
Total Stockholders' Equity170,825182,970
Total Liabilities and Stockholders' Equity$267,163$280,144

Item 15. Exhibits, Financial Statement Schedules.

FAQ

What is AngioDynamics's total liabilities & equity?
AngioDynamics (ANGO) reported total liabilities & equity of $267.16M in Q1 2026.
How has AngioDynamics's total liabilities & equity changed year-over-year?
AngioDynamics's total liabilities & equity decreased by 4.6% year-over-year, from $280.14M to $267.16M.
What is the long-term trend for AngioDynamics's total liabilities & equity?
Over 5 years (2021 to 2026), AngioDynamics's total liabilities & equity has grown at a -13.8% compound annual growth rate (CAGR), from $561.44M to $267.16M.
What does total liabilities & equity mean?
Total assets = total liabilities + total equity. This must always balance — a fundamental accounting identity.

Ask your AI about AngioDynamics's total liabilities & equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude